Subcutaneous administration of infliximab-attenuated silica-induced lung fibrosis. [electronic resource]
Producer: 20181213Description: 503-515 p. digitalISSN:- 1896-494X
- Animals
- Bronchoalveolar Lavage Fluid -- chemistry
- I-kappa B Proteins -- genetics
- Infliximab -- administration & dosage
- Injections, Subcutaneous
- Lung -- pathology
- Male
- NF-kappa B
- Nitric Oxide Synthase Type II -- genetics
- Pulmonary Fibrosis -- chemically induced
- Rats, Wistar
- Signal Transduction
- Silicon Dioxide
- Silicosis -- prevention & control
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.